ALA-PDT successfully treated Majocchi's granuloma by directly killing Trichophyton tonsurans and recruiting T

Lei Shi1, Qianqian Wu1, Jin Yang1

  • 1Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Baode Road 1278, Shanghai, 200443, China.

Abstract

Insights

Majocchi's granuloma (MG) treatment using aminolevulinic acid photodynamic therapy (ALA-PDT) shows promising results. This new approach effectively cleared infections and demonstrated potential for treating deep fungal perifolliculitis.

Area of Science:

  • Dermatology
  • Mycology
  • Photomedicine

Background:

  • Majocchi's granuloma (MG) is a deep fungal perifolliculitis often caused by Trichophyton tonsurans.
  • Conventional oral antifungal treatments for MG have limited efficacy and high recurrence rates.
  • Aminolevulinic acid photodynamic therapy (ALA-PDT) presents a novel therapeutic strategy for fungal infections.

Observation:

  • A case of refractory MG was treated with three sessions of ALA-PDT.
  • In vitro and in vivo studies investigated ALA-PDT's efficacy and mechanism against T. tonsurans.

Findings:

  • ALA-PDT successfully eliminated MG lesions, with mycological and pathological examinations confirming fungal clearance.
  • Experiments revealed ALA-PDT inhibits T. tonsurans by directly damaging fungal cells.
  • ALA-PDT also demonstrated an ability to recruit CD4+ T cells, suggesting an immune-mediated component.

Implications:

  • ALA-PDT offers a potentially effective, noninvasive treatment option for Majocchi's granuloma.
  • The treatment mechanism involves direct fungal cell destruction and a CD4+ T cell-mediated immune response.
  • Further research into ALA-PDT could lead to improved management of refractory deep fungal infections.

Related Concept Videos